Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) EPS (Basic): 2011-2025

Historic EPS (Basic) for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $0.11.

  • Mimedx Group's EPS (Basic) rose 120.00% to $0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.28, marking a year-over-year decrease of 54.84%. This contributed to the annual value of $0.29 for FY2024, which is 39.58% down from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's EPS (Basic) is $0.11, which was up 57.14% from $0.07 recorded in Q2 2025.
  • Mimedx Group's 5-year EPS (Basic) high stood at $0.39 for Q4 2023, and its period low was -$0.11 during Q1 2022.
  • Its 3-year average for EPS (Basic) is $0.09, with a median of $0.06 in 2024.
  • In the last 5 years, Mimedx Group's EPS (Basic) slumped by 266.67% in 2022 and then surged by 2,050.00% in 2023.
  • Quarterly analysis of 5 years shows Mimedx Group's EPS (Basic) stood at -$0.02 in 2021, then remained steady at -$0.02 in 2022, then spiked by 2,050.00% to $0.39 in 2023, then crashed by 87.18% to $0.05 in 2024, then soared by 120.00% to $0.11 in 2025.
  • Its EPS (Basic) was $0.11 in Q3 2025, compared to $0.07 in Q2 2025 and $0.05 in Q1 2025.